NCT00041977已完成3 期
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Determine the Effects of Doxycycline Hyclate 20 Mg Tablets [Periostat(R)] Administered Twice Daily for the Treatment of Acne Rosacea
CollaGenex Pharmaceuticals14 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2002年6月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
- 试验地点
- 14
研究概览
简要总结
The purpose of this study is to determine whether Periostat(R), Doxycycline Hyclate 20 mg Tablets, taken twice daily is effective in reducing the red and white heads and overall redness associated with rosacea.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy, post-pubescent male and females > age 18, with rosacea, 10 to 30, [papules and pustules] and < 2 nodules.
- •Presence of moderate to severe erythema.
- •Presence of telangiectasia.
- •Female patients must utilize one of the following methods of birth control throughout the study: IUD, diaphragm, a condom plus the use of a spermicidal gel or foam, oral contraceptives (provided patient has been utilizing this method for at least 4 months prior to baseline and has not changed the brand within this period). Patients may also participate if they are surgically sterilized, in a monogamous relationship with a sterile partner, or sign an agreement that they will abstain from sexual intercourse during the course of a study.
- •Patients must sign an informed consent form.
- •Negative pregnancy test and non-lactating.
排除标准
- •The initiation of a hormonal method of contraception within 4 months of baseline; or discontinuation during the course of study; or change in the actual product within 4 months of baseline or during the study.
- •The use of topical acne treatments within 2 weeks of baseline.
- •The use of systemic antibiotics within 4 weeks of baseline.
- •The use of an investigational drug with 90 days of baseline.
- •Pregnant women or women of child-bearing potential who are not using an adequate form of birth control as described in Item 4 of the Inclusion Criteria.
- •Nursing women.
- •Patients with a known hypersensitivity to tetracyclines.
- •Patients on clinically significant, concomitant drug therapy (See section below).
- •The use of any acne treatment during the course of the study.
- •The use of topical steroids 6 weeks prior to baseline and during the study.
- •The use of systemic corticosteroids 6 weeks prior to baseline and during the study.
- •The use of vasodilators 6 weeks prior to baseline or during the study.
- •The use of α-adrenergic receptor-blocking agents 6 weeks prior to baseline and during the study.
- •Prohibited Medications:
- •Chronic use (> 14 days) of sulfa drugs, erythromycin, cephalosporins, and quinolones.
- •The use of tetracycline antibiotics is prohibited.
- •Use of any acne treatment during the course of the study, including spironolactone.
- •Chronic use (> 14 days) of NSAIDs. Chronic use of aspirin at sub-analgesic doses (< 325 mg q.d.) may be used by those patient requiring platelet aggregation inhibitor.
- •Penicillin antibiotics should NOT be used during the course of this trial since the bacteriostatic action of doxycycline may interfere with the bactericidal action of penicillins.
- •Antacids and vitamins containing aluminum, calcium, or magnesium may impair drug absorption and should be taken at least 1.5 hours before or 3.0 hours after taking study medication.
研究者
研究点 (14)
Loading locations...
相似试验
已完成
4 期
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs PlaceboRosaceaNCT01308619Galderma R&D170
已完成
不适用
Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak SettingMycoplasma PneumoniaeNCT00207584Centers for Disease Control and Prevention
已完成
2 期
A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day PeriodDry EyeNCT00439400Alacrity Biosciences, Inc.160
已完成
4 期
Doxycycline In Lymphangioleiomyomatosis (LAM)Tuberous SclerosisLymphangioleiomyomatosisNCT00989742University of Nottingham24
已完成
2 期
Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic RetinopathyDiabetic RetinopathyNCT00511875Thomas Gardner30